A new (though perhaps imperfect) COVID vaccine is on the horizon. Getty Images
GOOD MORNING, PORTLAND! When you love me tenderly, I don t know if you re for real. But I like the way I feel inside. LET S GO TO PRESS.
• Pharmaceutical company Johnson & Johnson are preparing to ask for emergency use authorization for their single dose coronavirus vaccine, which is reportedly 85 percent effective at stopping the virus however against other variants (such as the one from South Africa) that effectiveness drops to an iffy low of 57 percent. Meanwhile regulators in the European Union have authorized the usage of AstraZeneca’s coronavirus vaccine though they are pretty intent on keeping the doses in Europe.